Junyang Lou is a Cardiology physician. OpenAlex indexes 31 publications with 469 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
455 Toll Gate Rd
Warwick, RI 028862759
Telephone
401-737-7010Provider last certified this registry record 30 Dec 2021.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20256 payments
- Amgen Inc.Program year202511 payments
- Alnylam Pharmaceuticals Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Beta blocker30.7%Metoprolol Succinate62%Carvedilol32%Atenolol2%Bisoprolol Fumarate2%Propranolol Hcl Er1%Sotalol1%Part D<11 patientsStatin16.5%Atorvastatin Calcium73%Rosuvastatin Calcium24%Pravastatin Sodium2%Part D<11 patients+ 14 more classes in this area
Blood & clotting
17.8%Factor Xa inhibitor11.1%Eliquis63%Xarelto37%Part D≥32 patientsP2Y12 inhibitor3.7%Clopidogrel100%Part D≥37 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.5%SGLT2 inhibitor0.8%Jardiance100%Part D<11 patientsPotassium supplement0.8%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-20045-ACC A FATAL CASE OF HYDROXYCHLOROQUINE-INDUCED INFILTRATIVE CARDIOMYOPATHY
Journal of the American College of Cardiology
2026 - 26-A-16813-ACC EXTERNAL VALIDATION OF THE VTE-PREDICT SCORE IN PATIENTS WITH PROVOKED VTE AND ENDURING RISK FACTORS: INSIGHTS FROM THE HI-PRO TRIAL
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”